Ronald M. MD Kurtz - Mar 9, 2023 Form 4 Insider Report for RxSight, Inc. (RXST)

Role: President & CEO, Director
Signature: /s/ Shelley Thunen, as Attorney-in-Fact
Stock symbol: RXST
Transactions as of: Mar 9, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/10/2023, 03:10 PM
Previous filing: Feb 13, 2023
Next filing: Dec 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RXST	Stock Option (right to buy)	Award	$0	+200K		$0.00	200K	Mar 9, 2023	Common Stock	200K	$14.95	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023.

Content

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023.